A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...

Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...

US biotech company Sage Therapeutics is to slash a third of its remaining jobs - just a year after cutting 40% of its prior workforce.

Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...

After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...

California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of ...

British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...

University Medical Center Groningen and SHINE Europe have secured an €10.5 million ($11 million) grant to boost European ...

The US Food and Drug Administration (FDA) has placed a partial clinical hold on the two-stage, open-label, randomized Phase ...

The European Medicines Agency’s (EMA) human health committee, CHMP, announced six positive opinions of novel medicines, as ...